JOHN ARKUSINSKI: Open Payments
NPI 1093714826 · ENNIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$945 in 49 payments from 20 companies in 2025. Trend: 2023 $1,239 · 2024 $953 · 2025 $945
Food & beverage: $945
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 10 | $238 |
| Axsome Therapeutics, Inc. | 4 | $76 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| PFIZER INC. | 3 | $68 |
| Lilly USA, LLC | 3 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| Amgen Inc. | 3 | $47 |
| Novo Nordisk Inc | 3 | $46 |
| ABBVIE INC. | 3 | $45 |
Products named: Korlym, Auvelity, JARDIANCE, Kerendia, VRAYLAR, AIRSUPRA, NURTEC ODT, CAPLYTA.
Industry payments across TX — which companies pay providers there.
